<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263259</url>
  </required_header>
  <id_info>
    <org_study_id>13419</org_study_id>
    <secondary_id>K01AA023233</secondary_id>
    <nct_id>NCT04263259</nct_id>
  </id_info>
  <brief_title>Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification</brief_title>
  <official_title>Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy as well as psychological and neurobiological mechanisms of
      mobile-delivered alcohol attentional bias modification among heavy drinking adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      By testing the efficacy and neurobiological mechanisms of behavior change (MOBC) following
      attentional bias modification among heavy drinking adults, the proposed study has the
      potential to unify dual process models and neurobiological models of addiction. The cognitive
      retraining will be delivered via mobile electronic devices to ensure the cost-effectiveness
      of these procedures, to allow a large amount of retraining to be delivered in an ecologically
      valid manner, and to facilitate broad dissemination of such procedures if found to be
      efficacious. Using an intensive longitudinal experimental design, subjects will be randomly
      assigned into one of 2 groups (attentional bias modification vs. attentional bias control).
      Ecological momentary assessment (EMA) data will be used to assess changes in cognitive and
      behavioral measures in situ, and functional magnetic resonance imaging (fMRI) scans before
      and after cognitive retraining will be used to examine neural changes in specific regions of
      interest (ROI).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2020</start_date>
  <completion_date type="Anticipated">April 13, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants are not informed about the nature of the mobile-delivered intervention or their assignment to the intervention or control condition.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Alcohol Use Frequency</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number of days of alcohol use during the 4-week ecological momentary assessment period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alcohol Use Quantity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number of standard drinks per day during the 4-week ecological momentary assessment period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative Alcohol-Related Consequences</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number negative consequences experienced 4-week ecological momentary assessment period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attentional Bias to Alcohol</measure>
    <time_frame>4 weeks</time_frame>
    <description>Measured with the Alcohol Dot Probe Task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol Cue-Induced Neural Reward Circuit Activation</measure>
    <time_frame>4 weeks</time_frame>
    <description>Regions of interest include ventral tegmental area, dorsal and ventral striatum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Alcohol; Harmful Use</condition>
  <arm_group>
    <arm_group_label>Attentional Bias Modification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants complete attentional bias modification using a dot probe task on a mobile device up to 5 times per day for a 28-day period (80 trials per assessment).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attentional Bias Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants complete attentional bias assessment-only using a dot probe task on a mobile device up to 5 times per day for a 28-day period (80 trials per assessment).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attentional Bias Modification</intervention_name>
    <description>Mobile-Delivered Cognitive Retraining Intervention</description>
    <arm_group_label>Attentional Bias Modification</arm_group_label>
    <other_name>Cognitive Retraining</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alcohol Use Disorders Identification Test greater than or equal to 8

          -  right-handed

        Exclusion Criteria:

          -  history of treatment for or diagnosis of alcohol use disorder/substance use disorder

          -  history of brain injury

          -  for females, currently pregnant

          -  any MRI safety contraindication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matthew R Pearson, Ph.D.</last_name>
    <phone>5059252322</phone>
    <email>mateo.pearson@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center on Alcoholism, Substance Abuse, &amp; Addictions</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew R Pearson, Ph.D.</last_name>
      <phone>505-925-2322</phone>
      <email>mateo.pearson@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mind Research Network</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claus</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be shared with other researchers.</ipd_description>
    <ipd_time_frame>Data can be requested from the PI by October 2020</ipd_time_frame>
    <ipd_access_criteria>Data will be shared with qualified scientists who enter a data sharing usage agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

